![EULAR Abstract summaries preview EULAR Abstract summaries preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/abstract-summaries-for-eular-1.jpg.webp?itok=w8F8o0CX)
The effect of secukinumab on non-radiographic axial spondyloarthritis at 2 years
A simplified overview of the abstract presented at EULAR June 2, 2021
![EULAR Abstract summaries preview EULAR Abstract summaries preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/abstract-summaries-for-eular-2.jpg.webp?itok=Gxf-FvMz)
Secukinumab effect across the axial spondyloarthritis spectrum at 1 year
A simplified overview of the abstract presented at EULAR June 3, 2021.
![EULAR Abstract summaries preview EULAR Abstract summaries preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/abstract-summaries-for-eular-3.jpg.webp?itok=x42esRcb)
Using sensitive ultrasound imaging to understand response of psoriatic arthritis to secukinumab over 24 weeks
A simplified overview of the abstract presented at EULAR June 4, 2021.
![EULAR Abstract summaries preview EULAR Abstract summaries preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/abstract-summaries-for-eular-4.jpg.webp?itok=KKFYxPLJ)
Secukinumab effect in two types of arthritis seen in children and adolescents at two years
A simplified overview of the abstract presented at EULAR June 5, 2021.